Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Ignite Creation Date:
2025-12-25 @ 1:17 AM
Ignite Modification Date:
2025-12-25 @ 11:26 PM
NCT ID:
NCT00966693
Description:
None
Frequency Threshold:
0
Time Frame:
Baseline to study completion up to 9 years
Study:
NCT00966693
Study Brief:
Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma
Event Groups(If Any):
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| RTD (Cohort 1, Phase 1) | Oral Revlimid 15mg, Thalidomide 100mg, Dexamethasone 40mg\*21 days+ 7 days rest and reevaluation=28 day cycle | 0 | None | 0 | 3 | 3 | 3 | View |
| RTD (Cohort 2, Phase 1) | Oral Revlimid 25mg, Thalidomide 100mg, Dexamethasone \*21 days+ 7 days rest and reevaluation=28 day cycle | 0 | None | 0 | 3 | 3 | 3 | View |
| RTD (Cohort 3, Phase 1) | Oral Revlimid 25mg, Thalidomide 200mg, Dexamethasone 40mg\*21 days+ 7 days rest and reevaluation=28 day cycle | 1 | None | 1 | 9 | 9 | 9 | View |
| RTD (Cohort 2, Phase 2) | Oral Revlimid 25mg, Thalidomide 100mg, Dexamethasone \*21 days+ 7 days rest and reevaluation=28 day cycle | 0 | None | 7 | 49 | 49 | 49 | View |
Serious Events(If Any):
Serious Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Death | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Altered Mental Status | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3.0 | View |
| Urinary Tract Infection | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI CTCAE v3.0 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Abdominal Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Muscle Weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
Other Events(If Any):
Other Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Dry Eye Syndrome | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Dry Skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE v3.0 | View |
| Dyspepsia | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Edema Limbs | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Endocrine (other) | SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCI CTCAE v3.0 | View |
| Esophogeal Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Eye Muscle Weakness | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Eye Pain | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Flashing Vision | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Flu-like Symptoms | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Gait Abnormal | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Gastric Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3.0 | View |
| Gastrointestinal General | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Glucose intolerance | SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCI CTCAE v3.0 | View |
| Headache | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Hearing Loss | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | NCI CTCAE v3.0 | View |
| Hematoma | SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI CTCAE v3.0 | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Epstaxis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Hemorrhoidal/hemorrhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Hemorrhage Urinary | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI CTCAE v3.0 | View |
| Hiccough | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Hypercalcemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3.0 | View |
| INR Increase | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3.0 | View |
| Irratibility | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3.0 | View |
| Jejunal | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Joint Disorder | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Joint Pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Leukopenia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Lymphatics (Other) | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE v3.0 | View |
| Localized Edema | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Lymphopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | NCI CTCAE v3.0 | View |
| Memory Impairement | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Metabolic/Laboratory (Other) | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Mucosal Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3.0 | View |
| Mucositis Oral | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Musculoskeletal (Other) | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Muscle Weakness Lower Limb | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Muscle Weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Musculoskelatal (Other) | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Myalgia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Myositis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Mycardial Ichemia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Neck Pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Neurology (Other) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| ANC Decrease | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Ocular/Visual (Other) | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Oral Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Osteoporsis | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Otitis media | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | NCI CTCAE v3.0 | View |
| Pain | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Pain (Other) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Pain in extremity | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Peripheral motor neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Pericardial Effusion | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Pharyngitis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Photosensitivity | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Photophobia | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Thromboctopenia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Pulmonary (Other) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Rash acneform | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE v3.0 | View |
| Rash desquamating | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE v3.0 | View |
| Renal/Genitourinary (Other) | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI CTCAE v3.0 | View |
| Retinopathy | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Rhinitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3.0 | View |
| Hypoalbumenia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypocalcemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypomagnesemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypermagnesmia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypoglycemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypophosphatemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hyponatremia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypernatremia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypercholesteremia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Sinus Brdaycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Sinus Pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Skin Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3.0 | View |
| Hyperhidrosis | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Taste Alteration | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Tinitus | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | NCI CTCAE v3.0 | View |
| Speech Disorder | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Tooth disorder | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Toothache | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Tooth infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3.0 | View |
| Treatment related to Secondary Malignancy | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | NCI CTCAE v3.0 | View |
| Tremor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |
| Tumor Lysis Syndrome | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE v3.0 | View |
| Upper Respiratory Infection | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Urinary Urgency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI CTCAE v3.0 | View |
| Urinary Retention | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI CTCAE v3.0 | View |
| Urinary Tract Infection | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | NCI CTCAE v3.0 | View |
| Urostomy stenosis | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | NCI CTCAE v3.0 | View |
| Vaginal hemmorrhage | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | NCI CTCAE v3.0 | View |
| Vision blurred | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Vascular (other) | SYSTEMATIC_ASSESSMENT | Vascular disorders | NCI CTCAE v3.0 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Voice Alteration | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Watering Eyes | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Weight Gain | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE v3.0 | View |
| Activated PTT | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Acidosis | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Abdominal Pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Adult Respiratory Distress | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Agitation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3.0 | View |
| ALT Increase | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Alkaline Phosphate increase | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Allergy | SYSTEMATIC_ASSESSMENT | Immune system disorders | NCI CTCAE v3.0 | View |
| Anal Hemmorhage | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | NCI CTCAE v3.0 | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3.0 | View |
| AST Increase | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Apnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Atrial Fibrillation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Atrial Injury | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Auditory Ear (Other) | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | NCI CTCAE v3.0 | View |
| Autoimmune Disorder (Other) | SYSTEMATIC_ASSESSMENT | Immune system disorders | NCI CTCAE v3.0 | View |
| Back Pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Hyperbilirubia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hypocarpnia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Hyperuricemia | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Blood Bone Marrow (other) | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Bone Development Abnormal | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| BonePain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | NCI CTCAE v3.0 | View |
| Bronchial Hemmorhage | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Bronchospasm | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Brusing | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE v3.0 | View |
| Catheter related infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | NCI CTCAE v3.0 | View |
| Cataract | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Cardiac General (Other) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Chest pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Hypocaligulopathy | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Confusion | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3.0 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Conjunctival disorder | SYSTEMATIC_ASSESSMENT | Eye disorders | NCI CTCAE v3.0 | View |
| Constitutional Symptoms | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Cushingoid | SYSTEMATIC_ASSESSMENT | Endocrine disorders | NCI CTCAE v3.0 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | NCI CTCAE v3.0 | View |
| Creatinine increase | SYSTEMATIC_ASSESSMENT | Investigations | NCI CTCAE v3.0 | View |
| Cytokine release syndrome | SYSTEMATIC_ASSESSMENT | Immune system disorders | NCI CTCAE v3.0 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | General disorders | NCI CTCAE v3.0 | View |
| Depressed Conciousness Level | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3.0 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | NCI CTCAE v3.0 | View |
| Dermatological/Skin (other) | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | NCI CTCAE v3.0 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | NCI CTCAE v3.0 | View |
| Diastolic Dysfunction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | NCI CTCAE v3.0 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | NCI CTCAE v3.0 | View |